LOC: Leaders in Oncology Care
95 Harley Street
London, W1G 6AF
T: +44 (0) 20 7317 2500
F: +44 (0) 20 7009 4200
When we set up the LOC in 2005 we were acutely aware that there was one major area where we couldn’t offer everything a patient with cancer needed; that was access to clinical trials, simply because there was no clinical trials infrastructure available in the private sector.
We therefore approached a team of colleagues in the USA who were running the Sarah Canon Research Institute (SCRI) network. SCRI is one of the largest cancer trials network in the world with access to the latest oncology drugs and expertise to set up a clinical trials unit.
Both institutions found many similarities and SCRI agreed to open a branch of here in London, at 93 Harley Street, right next door to the LOC at 95-97 Harley Street. We were even able to break through our common wall to obtain direct access.
The Sarah Cannon Research UK Clinical trials unit at 93 Harley Street (http://sarahcannonresearch.co.uk) is designed to look almost identical to the treatment suite at the LOC, so if you are referred for a clinical trial you will feel completely at home.
So when you have treatment with LOC, you’ll benefit from direct access to some of the most promising new cancer drug trials in the world, through this partnership with SCRI.
Many of our consultants are personally involved in these clinical trials, so we are fully informed on the developments that are most likely to improve your condition.
When you take part in clinical trials at SCRI at 93 Harley Street your consultant at the LOC will continue to be closely involved in your care.
All clinical trials at Sarah Cannon Research UK follow the strict rules set by the Department of Health and are approved by an Ethics Committee in the UK, to ensure that the trial is ethical and that the highest standards of safety will be maintained.
Participation in clinical trials is entirely voluntary, and you can decide to halt your treatment at any time without giving a reason. However the trials are designed to maximise the benefits and minimise any risks for all participants.
You’ll receive careful monitoring during and after the study, which means that any changes in your health – whether or not they are related to the treatment you’re having – can be recognised and dealt with earlier than if you weren’t in a trial. Whatever your reason for participating, you can be sure you’ll receive the highest quality cancer care at all times.
If you would like to know more about clinical trials at Sarah Cannon Research UK, your consultant can advise you on what is relevant to your condition. If you want to search for information yourself, you will find more information about clinical trials and a list of clinical trials open to recruitment at SCRI by clicking here. http://sarahcannonresearch.co.uk/for-patients/open-clinical-trials/.